News
Nueva píldora contra obesidad de Novo Nordisk, Amycretin, supera a Wegovy en un ensayo inicial
La esperadísima nueva píldora contra la obesidad muestra un potencial para una mayor y más rápida pérdida de peso que Wegovy.
![[Foto original: Artist Nadia Russ/Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/07/17093837/3-1.jpg)
![[Imagen: RRSS Universal Pictures México]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/07/16172621/la-odisea-gandhi-christopher-nolan.jpg)
![[Imágenes: Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/07/15135648/p-1-91572643-despite-the-growth-of-some-ai-schools-like-alpha-research-doesnt-show-that-ai-tutors-are-better-than-human-teachers.webp)
![[Foto: Unsplash]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/07/17092511/Diseno-sin-titulo-2026-07-17T092125.351.jpg)
